Key facts
- This page summarizes Bonne J. Adams's Form 3 filing for Tracon Pharmaceuticals, Inc..
- 0 reported transactions and 11 derivative rows are listed below.
- Accepted by SEC: 09 Feb 2023, 20:26.
Bonne J. Adams - 01 Feb 2023 Form 3 Insider Report for Tracon Pharmaceuticals, Inc.
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- N/A
- Reported as of
- 01 Feb 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Scott B. Brown, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Bonne J. Adams filed Form 3 for Tracon Pharmaceuticals, Inc. on 09 Feb 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TCON
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,267
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 516
- Exercise price
- $13.35
- Footnotes
- F3
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,360
- Exercise price
- $13.35
- Footnotes
- F4
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,015
- Exercise price
- $70.43
- Footnotes
- F5
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,078
- Exercise price
- $70.43
- Footnotes
- F5, F6
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,122
- Exercise price
- $146.20
- Footnotes
- F7
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,499
- Exercise price
- $51.50
- Footnotes
- F8
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,591
- Exercise price
- $21.50
- Footnotes
- F9
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,499
- Exercise price
- $7.90
- Footnotes
- F10
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,600
- Exercise price
- $4.02
- Footnotes
- F11
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 55,000
- Exercise price
- $9.14
- Footnotes
- F12
TCON
holding
Derivative
Employee Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $2.32
- Footnotes
- F13
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 13 footnotes
Footnote F1
Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2021.
Footnote F2
Includes 767 of the 2,595 restricted stock units granted to the Reporting Person on January 21, 2016. 1/4th of the award vested annually on each anniversary date of the grant. The Reporting Person sold the other 1,828 restricted stock units following settlement and prior to being required to report pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended.
Footnote F3
The shares subject to the option vest and become exercisable in 48 equal monthly installments commencing March 14, 2013.
Footnote F4
The shares subject to the option vest and become exercisable in 48 equal monthly installments commencing May 23, 2013.
Footnote F5
1/4th of the shares subject to this option shall vest on the first anniversary of October 3, 2014. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.
Footnote F6
The shares subject to this option will be forfeited if the Company's initial public offering is not completed on or before March 31, 2015.
Footnote F7
1/4th of the shares subject to this option shall vest on the first anniversary of March 25, 2015. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.
Footnote F8
1/4th of the shares subject to this option shall vest on the first anniversary of January 20, 2017. The remaining shares vest and become exercisable in 36 equal monthly installments on the 20th of each month thereafter.
Footnote F9
1/4th of the shares subject to this option shall vest on the first anniversary of February 21, 2018. The remaining shares vest and become exercisable in 36 equal monthly installments on the 21st of each month thereafter.
Footnote F10
1/4th of the shares subject to this option shall vest on the first anniversary of January 29, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments on the 29th of each month thereafter.
Footnote F11
1/4th of the shares subject to this option shall vest on the first anniversary of January 31, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments on the 31st of each month thereafter.
Footnote F12
1/4th of the shares subject to this option shall vest on the first anniversary of January 29, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments on the 29th of each month thereafter.
Footnote F13
1/4th of the shares subject to this option shall vest on the first anniversary of January 28, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments on the 28th of each month thereafter.